2026年4月8日，康灃生物科技（上海）股份有限公司（简称“康沣生物-B”，股票代码：06922）发布截至2026年3月31日的月报表。报告显示，公司注册股本与已发行股份在本月均未发生新增发行、购回、注销或库藏股变动，股本结构保持稳定。
根据公告，截至3月底，公司H股已发行股份数量为149,033,579股，非上市普通股数量为95,671,421股，合计占注册股本人民币2.45亿元（折合244,705,000元面值）。当月无购回、现金认购或其他股本变动活动，公司亦未涉及任何股份期权计划、可换股票据或其他发行安排。
公司同时确认，截至2026年3月31日，H股的公众持股量已符合香港联交所上市规则相关规定。此份月报表由董事朱军签署并提交。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.